The cardiovascular drugs market is highly competitive, with several key players accounting for a significant share of the market. The major players in the market include Pfizer Inc., Novartis AG, Merck & Co., Inc., AstraZeneca plc, Bristol-Myers Squibb Company, and Sanofi S.A.

These companies have a strong presence in the market due to their extensive product portfolios, high R&D investments, and widespread distribution networks. The market share of these companies varies depending on the drug class and geography.

For instance, Pfizer Inc. dominates the antiplatelet agents market, while Novartis AG is a leading player in the ACE inhibitors market. In terms of geography, Sanofi S.A. has a strong presence in Europe, while Merck & Co., Inc. dominates the market in North America.

The competition in the cardiovascular drugs market is expected to intensify in the coming years, as more players enter the market and existing players focus on expanding their product portfolios and improving their distribution networks.

Read more: https://cmiaspireblog.blogspot.com/2023/05/exploring-growth-and-trends-of-global.html